LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-2.81 | ₹2.24 | ₹-0.75 | ₹-4.30 | ₹13.59 |
What is the latest Earnings Per Share (EPS) of LYKA LABS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-2.81 |
| Mar2025 | ₹2.24 |
| Mar2024 | ₹-0.75 |
| Mar2023 | ₹-4.30 |
| Mar2022 | ₹13.59 |
How is Earnings Per Share (EPS) of LYKA LABS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2.81 | Negative | |
| Mar2025 | ₹2.24 | Positive | |
| Mar2024 | ₹-0.75 | Negative | |
| Mar2023 | ₹-4.30 | Negative | |
| Mar2022 | ₹13.59 | - | |
Compare Earnings Per Share (EPS) of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹271.5 Cr | 2.1% | 24.3% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 2.1% |
24.3% |
-26.5% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses